Myocardial Effects in Patients with ATTRv with Polyneuropathy Treated with Patisiran or Vutrisiran

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 12, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

July 31, 2026

Conditions
Transthyretin AmyloidosisAmyloidosis, Hereditary
Interventions
OTHER

Six minutes walk test

Six minutes walk test just before first intake of treatment and after 1 and 2 years

OTHER

Kansas City questionnaire

Kansas City questionnaire just before first intake of treatment and after 1 and 2 years

OTHER

COMPASS31 self questionnaire

Compass31 self questionnaire assessing dysautonomia just before first intake of treatment and after 1 and 2 years

Trial Locations (8)

Unknown

RECRUITING

CHU Bordeaux Haut-Levêque, Bordeaux

RECRUITING

APHP Henri Mondor, Créteil

RECRUITING

CHU Grenoble Alpes, Grenoble

RECRUITING

APHM Timone, Marseille

RECRUITING

CHU Nancy Institut Louis Mathieu, Nancy

NOT_YET_RECRUITING

APHP Bichat, Paris

RECRUITING

CHU Rennes, Rennes

RECRUITING

CHU Rangueil Toulouse, Toulouse

All Listed Sponsors
lead

Rennes University Hospital

OTHER